SCHEMBL2725932

SCHEMBL2725932

COc1ccc(-c2c3cccc(F)c3c(-c3c(F)c(F)c(OC)c(F)c3F)c3c(F)c(F)c(F)c(F)c23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.36
SYK P43405 1/20 0.36
MAOB P27338 2/20 0.36
ENPP1 P22413 1/20 0.35
RELA Q04206 3/20 0.33
ALDH1A1 P00352 2/20 0.33
ABCG2 Q9UNQ0 2/20 0.33
NPC1 O15118 2/20 0.33
TP53 P04637 2/20 0.33
MAPT P10636 2/20 0.33
NFKB1 P19838 2/20 0.33
RAB9A P51151 2/20 0.33
NFKB2 Q00653 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
HSD17B10 Q99714 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2726658 0.95 ACHE (0.40) ACHESYKMAOBENPP1RELA
SCHEMBL2728452 0.94 ACHE (0.37) ACHESYKMAOBENPP1RELA
SCHEMBL2709628 0.91 ACHE (0.40) ACHESYKMAOBENPP1RELA
SCHEMBL2728503 0.90 CYP1A2 (0.40) ACHEALDH1A1ABCG2SMN1; SMN2MAPK1
SCHEMBL2726606 0.89 ACHE (0.40) ACHESYKMAOBENPP1RELA
SCHEMBL2729138 0.88 ACHE (0.37) ACHESYKMAOBENPP1RELA
SCHEMBL2727156 0.88 KDM4E (0.34) ALDH1A1SMN1; SMN2MAPK1HSD17B10CYP1A2
SCHEMBL2727123 0.88 KDM4E (0.34) ALDH1A1SMN1; SMN2MAPK1HSD17B10CYP1A2
SCHEMBL12086117 0.88 KDM4E (0.34) ALDH1A1SMN1; SMN2MAPK1HSD17B10CYP1A2
SCHEMBL2727154 0.87 ACHE (0.43) ACHEMAOBENPP1ALDH1A1ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2445987-B1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECH INC (US) 2018-05-02 EP disclosed
EP-2445987-B1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECH INC (US) 2018-05-02 EP disclosed
US-8257620-B2 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. (US) 2012-09-04 US disclosed
US-8257620-B2 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. (US) 2012-09-04 US disclosed
EP-2445987-A1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS Cyalume Technologies, Inc (US) 2012-05-02 EP disclosed
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. 2010-12-30 US disclosed
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. 2010-12-30 US disclosed
WO-2010151654-A1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECHNOLOGIES, INC. (US) 2010-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYP2F1, FLAD1, AFF1 ACHE 187/4885SYK 2951/4885MAOB 67/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.